Actovegin vs Sermorelin
Actovegin and Sermorelin are both peptide compounds evaluated on Vial: Actovegin is not FDA approved for human use with clinical-trial evidence, and Sermorelin is legally compoundable with clinical-trial evidence.
Vial summary · compiled from public records
At a glance
Sermorelin
- Category
- Peptide
- FDA / legal status
- Legally Compoundable
- Route
- Subcutaneous
Side by side
| Field | Actovegin | Sermorelin |
|---|---|---|
| Category | Peptide | Peptide |
| Brand names | — | — |
| FDA / legal status | Gray Market | Legally Compoundable |
| Evidence tier | Clinical Trials | Clinical Trials |
| Administration route | — | Subcutaneous |
| Compounding access | Not FDA approved, limited regulated access | Legally Compoundable |
| Providers on Vial | 0 listed | 27 listed |
| Typical price band | Varies by provider | $$ to $$$ |
Verified providers offering each
Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
Actovegin0 top providers
No surfaceable providers currently list Actovegin on Vial.
See all 0 providers offering actovegin →About each compound
About Actovegin
Actovegin is a deproteinized hemodialysate of calf blood containing low-molecular-weight peptides, nucleosides, amino acids, and oligosaccharides that improve cellular oxygen utilization and glucose uptake. It is approved and widely used in Europe, Russia, and Asia for ischemic conditions, diabetic neuropathy, wound healing, and stroke recovery. Athletes and biohackers use it off-label for enhanced recovery and cognitive performance.
About Sermorelin
A synthetic analog of growth hormone-releasing hormone (GHRH), this 29-amino acid peptide stimulates the pituitary gland to produce and secrete endogenous growth hormone through binding to GHRH receptors. It functions by mimicking the N-terminal bioactive portion of native GHRH, promoting pulsatile GH release while preserving the body's natural feedback mechanisms. Primary applications include diagnostic testing of pituitary function and therapeutic use in growth hormone deficiency.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.